Laboratory Evaluation for Crohn's Disease and Ulcerative Colitis
For initial evaluation of suspected IBD, order a complete blood count, comprehensive metabolic panel (including liver enzymes, albumin, and renal function), C-reactive protein, iron studies, vitamin B12, and fecal calprotectin. 1, 2
Essential Blood Tests
The most recent BSG 2025 guidelines 1 and ECCO-ESGAR 2025 guidelines 2 establish a multimodal diagnostic approach requiring specific laboratory markers:
Core Laboratory Panel
- Complete blood count (CBC) - assess for anemia (common in both CD and UC), leukocytosis, and thrombocytosis
- Comprehensive metabolic panel including:
- Electrolytes
- Liver enzymes (ALT, AST, alkaline phosphatase)
- Serum albumin (low levels indicate inflammation and malnutrition; particularly important as low albumin predicts poor response to biologics)
- Renal function (creatinine, BUN)
- C-reactive protein (CRP) - marker of systemic inflammation, though note that approximately 20% of patients with active Crohn's disease may have normal CRP 3
- Erythrocyte sedimentation rate (ESR) - less sensitive than CRP but still useful 4
- Iron studies - to assess iron deficiency anemia
- Vitamin B12 - particularly important in Crohn's disease with ileal involvement 3
Stool Studies
Fecal calprotectin is the single most important stool biomarker with pooled sensitivity of 93-95% and specificity of 91-96% for diagnosing IBD 3. At a cutoff of ≤50 μg/g, fecal calprotectin has 87% sensitivity and 92% specificity 2. The diagnostic precision is greater with a cutoff of 100 μg/g compared to 50 μg/g 3.
Mandatory infectious workup:
- Stool culture for bacterial pathogens
- Clostridioides difficile toxin testing - must be excluded in any suspected IBD flare 4
- Consider Cytomegalovirus testing in severe cases 4
- Ova and parasites if travel history or epidemiologic risk factors present
Monitoring Disease Activity
For established IBD, the 2025 BSG guidelines 1 recommend using fecal calprotectin to monitor disease activity in patients with known disease location and baseline values.
For ulcerative colitis in symptomatic remission 5:
- Fecal calprotectin <150 mg/g reliably rules out active inflammation
- Normal fecal lactoferrin can also rule out active inflammation
- Normal CRP may rule out active inflammation (though less reliable than stool markers)
Important caveat: Fecal lactoferrin has similar diagnostic utility to calprotectin but is less widely studied 3.
What NOT to Routinely Order
Serologic markers (pANCA, ASCA) have limited accuracy and are not recommended for routine diagnosis or differentiation between CD and UC 6. Their sensitivity and specificity are insufficient for screening purposes 3.
Genetic testing for IBD susceptibility SNPs does not allow diagnosis and should not be ordered 6.
Clinical Context Matters
The 2021 WSES-AAST emergency guidelines 4 emphasize that in acute presentations, pre-albumin can be added to assess both nutritional status and degree of inflammation. In emergency settings, lipase should also be included to evaluate for pancreatitis (which can be medication-related or disease-related).
Critical pitfall: Always establish baseline laboratory values at diagnosis for future comparison 3. This allows you to track individual patient trends, which is more valuable than single time-point measurements.
The diagnosis ultimately requires integration of these laboratory findings with endoscopic evaluation, histology, and cross-sectional imaging - no single test is diagnostic 1, 2, 6. However, the laboratory panel outlined above provides the essential biochemical foundation for both diagnosis and ongoing management.